Robert Petit, MD, Chief Scientific Officer of Advaxis, Inc. summarizes the practice-changing studies on immuno-oncology coming out of ASCO 2017. This was recorded at the 2017 ASCO Annual Meeting in Chicago, IL.
Robert Petit, MD, Chief Scientific Officer of Advaxis, Inc. summarizes the practice-changing studies on immuno-oncology coming out of ASCO 2017. This was recorded at the 2017 ASCO Annual Meeting in Chicago, IL.